TIL vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

TIL

58.6
AI Score
VS
TIL Wins

CBIO

58.4
AI Score

Investment Advisor Scores

TIL

59score
Recommendation
HOLD

CBIO

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TIL CBIO Winner
Net Income -101.44M -48.12M CBIO
Operating Income -101.81M -51.09M CBIO
ROE -16.9% -29.5% TIL
ROA -15.7% -26.3% TIL
Total Assets 647.40M 182.76M TIL
Cash 20.40M 171.59M CBIO
Current Ratio 16.30 9.66 TIL
Free Cash Flow -118.72M -28.56M CBIO

Relative Price Performance (Last 90 Days)

TIL 1M: -6.1% · 3M: -6.5% CBIO 1M: -22.8% · 3M: -15.6%

Current Technical Phase

TIL

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.5%) with fading momentum, RSI 47

RSI (14): 46.7 · Price: $7.22

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

Fundamentals Snapshot

Metric TIL CBIO
Market Cap — —
Forward P/E 0.0 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 1.0%
Operating Margin 0.0% -14.3%
EPS -4.38 -0.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TIL is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.